Lysipressin Acetate

• CAT Number: I031316
• CAS Number: 50-57-7
• Molecular Formula: C48H68N12O15S2
• Molecular Weight: 1117.26
• Purity: 98%
• Synonyms: Lysipressin Acetate. L-Lysine vasopressin; Lypressin; Lysine pitressin; Lysine vasopressin; Lysine-ADH; Lysopressin; Lysylvasopressin; Oxytocin, 3-(L-phenylalanine)-8-L-lysine-; Postacton; Syntopressin; Vasophysin; Vasopressin-8-lysine; [8-Lysine]Vasopressin.
• Solubility: Soluble in DMSO, not in water
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: acetic acid;(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
• InChI: InChI=1S/C46H65N13O12S2.C2H4O2/c47-17-5-4-9-29(40(65)52-22-38(51)63)54-45(70)35-10-6-18-59(35)46(71)34-24-73-72-23-28(48)39(64)55-31(20-26-11-13-27(60)14-12-26)43(68)56-32(19-25-7-2-1-3-8-25)42(67)53-30(15-16-36(49)61)41(66)57-33(21-37(50)62)44(69)58-34;1-2(3)4/h1-3,7-8,11-14,28-35,60H,4-6,9-10,15-24,47-48H2,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,67)(H,54,70)(H,55,64)(H,56,68)(H,57,66)(H,58,69);1H3,(H,3,4)/t28-,29-,30-,31-,32-,33-,34-,35-;/m0./s1
• InChIKey: NKWAIKZITYLOMT-DHSVNZEYSA-N
• SMILES: CC(=O)O.C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N

Lysipressin acetate（Cat No.:I031316）is a synthetic analog of the hormone vasopressin, which is involved in regulating water balance and blood pressure in the body. It functions by binding to vasopressin receptors, helping to control the retention of water by the kidneys and constriction of blood vessels. Lysipressin acetate is primarily researched for its potential therapeutic applications in conditions such as diabetes insipidus, hypotension, and certain types of shock. While it shares similar effects with vasopressin, its unique properties may offer advantages in specific clinical settings, although further studies are needed to confirm its safety and efficacy.